Oct. 2, 2020—Vanderbilt researchers awarded one of NSF’s 24 new projects to drive future manufacturing One of the challenges of drug delivery systems is to optimize their targeting properties so therapeutic compounds used in smaller amounts reach only a specific area of the body and result in little or no side effects. The ability to engineer the...
Apr. 15, 2020—A multidisciplinary team of investigators at Vanderbilt University and Vanderbilt University Medical Center has received a program project grant from the National Cancer Institute to explore extracellular RNA in colorectal cancer.
Dec. 5, 2017—Eleven Vanderbilt University faculty members named to endowed chairs were recognized for their outstanding scholarship and research during a celebration at the Student Life Center Nov. 29.
Nov. 25, 2016—Nine Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.
Apr. 28, 2016—A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.”
Feb. 18, 2016—Investigators at Vanderbilt University Medical Center have published research regarding an important feature of colorectal cancer (CRC) that could eventually lead to the development of non-invasive means of monitoring cancer progression. After lung cancer, CRC is the second-most lethal cancer in the United States.
Feb. 13, 2014—Vanderbilt University’s Warren Sandberg, M.D., Ph.D., and Alissa Weaver, M.D., Ph.D., have been appointed to three-year terms on the Association of American Medical Colleges (AAMC) Council of Faculty and Academic Societies. The council is charged with identifying and communicating critical issues faced by medical school faculty members as they relate to the creation and implementation...
Dec. 19, 2013—Two features of invasive cancer cells — invadopodia and exosomes — are linked together, Vanderbilt University investigators have discovered.
Oct. 4, 2012—Vanderbilt investigators have identified how two key components of cancer's invasive "switch" — the series of signaling events that turn on a tumor cell’s invasive behavior — work together.